EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Polymyxin B and the Pulmonary Peril: A Case Series of Acute Respiratory Failure

Lovely Thomas iD, John Victor Peter iD, Binu Susan Mathew iD, Sara Jose iD, Lisa Merin Joseph iD, Jeethu Joseph Eapen iD, Sirish Chandra Srinath Patloori iD, Binila Chacko iD

Case Reports in Critical Care · 2026-01 · 2026 (1)

DOI: 10.1155/crcc/5569011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Case Reports in Critical Care, online erschienen am 21.09.2026. Verfasst von Lovely Thomas und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care, Christian Medical College, Vellore, India, cmch-vellore.edu. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The neurotoxicity potential of polymyxin B is underrecognized.

Results

Four critically ill patients treated with polymyxin B for suspected or confirmed nosocomial Gram‐negative infections developed acute hypercapnic respiratory failure temporally associated with polymyxin B administration. Respiratory support escalated from room air or low‐flow oxygen to noninvasive or invasive mechanical ventilation after one, two, five, and seven doses of polymyxin. No alternative explanation for the abrupt deterioration was identified after clinical evaluation. Following cessation of polymyxin ( n = 3) or dose reduction ( n = 1), all patients were liberated from ventilation within 60 h. Measured polymyxin concentrations were above the therapeutic range in all patients; however, the delayed timing of sampling, measured at variable intervals after the respiratory events, limits conclusions regarding causality and dose‐dependent toxicity.

Conclusion

Polymyxin B should be considered as a potential cause of acute hypercapnic respiratory failure in critically ill patients when no alternative explanation is apparent. Both idiosyncratic susceptibility and drug accumulation may contribute, although the delayed timing of drug concentration measurements precludes firm conclusions regarding dose‐dependent toxicity. Further prospective studies are required to define the mechanisms and risk factors.

Schlagwörter

Stichwörter der Autor:innen

critically illhypercapnicpolymyxin Brespiratory failuretoxicity

Autor:innen und Institutionen

  • Department of Critical Care, Christian Medical College, Vellore, India, cmch-vellore.edu.
  • Department of Clinical Pharmacology, Christian Medical College, Vellore, India, cmch-vellore.edu.
  • Department of Nephrology, Christian Medical College, Vellore, India, cmch-vellore.edu.
  • Department of Cardiology, Christian Medical College, Vellore, India, cmch-vellore.edu.

ORCID-Profile: Lovely Thomas, John Victor Peter, Binu Susan Mathew, Sara Jose, Lisa Merin Joseph, Jeethu Joseph Eapen, Sirish Chandra Srinath Patloori, Binila Chacko

Zitieren

APA

Thomas, L., Peter, J. V., Mathew, B. S., Jose, S., Joseph, L. M., Eapen, J. J., Patloori, S. C. S., & Chacko, B. (2026). Polymyxin B and the Pulmonary Peril: A Case Series of Acute Respiratory Failure. Case Reports in Critical Care, 2026(1). https://doi.org/10.1155/crcc/5569011

Vancouver

Thomas L, Peter JV, Mathew BS, Jose S, Joseph LM, Eapen JJ, et al. Polymyxin B and the Pulmonary Peril: A Case Series of Acute Respiratory Failure. Case Reports in Critical Care. 2026;2026(1). doi:10.1155/crcc/5569011

BibTeX
@article{Thomas2026,
  author = {Thomas, Lovely and Peter, John Victor and Mathew, Binu Susan and Jose, Sara and Joseph, Lisa Merin and Eapen, Jeethu Joseph and Patloori, Sirish Chandra Srinath and Chacko, Binila},
  title = {Polymyxin B and the Pulmonary Peril: A Case Series of Acute Respiratory Failure},
  journal = {Case Reports in Critical Care},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/crcc/5569011}
}
Kostenlos starten →